BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7208595)

  • 1. Distribution of antipyrine, phenylbutazone and phenytoin in experimental renal failure.
    Van Peer AP; Belpaire FM; Rosseel MT; Bogaert MG
    Pharmacology; 1981; 22(2):139-45. PubMed ID: 7208595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of drugs in serum, blood cells and tissues of rabbits with experimental acute renal failure.
    Van Peer AP; Belpaire FM; Bogaert MG
    Pharmacology; 1981; 22(2):146-52. PubMed ID: 7208596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits.
    Van Peer AP; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1980 Feb; 32(2):135-6. PubMed ID: 6103036
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in rabbits with experimental renal failure.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):346-7. PubMed ID: 708161
    [No Abstract]   [Full Text] [Related]  

  • 6. Distribution of phenytoin and phenylbutazone in normal and uraemic rabbits.
    van Peer AP; Belpaire FM; Bogaert MG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):348. PubMed ID: 708162
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetic analysis of phenytoin disposition in rats with experimental renal and hepatic diseases.
    Itoh T; Sawada Y; Lin TH; Iga T; Hanano M
    J Pharmacobiodyn; 1988 May; 11(5):289-308. PubMed ID: 3171873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury.
    Markowsky SJ; Skaar DJ; Christie JM; Eyer SD; Ehresman DJ
    Ann Pharmacother; 1996 May; 30(5):443-8. PubMed ID: 8740320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine-phenytoin interaction: effect on serum phenytoin concentration and antipyrine test.
    Neuvonen PJ; Tokola RA; Kaste M
    Eur J Clin Pharmacol; 1981; 21(3):215-20. PubMed ID: 7318881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
    Lynn K; Braithwaite R; Dawling S; Rosser R
    Eur J Clin Pharmacol; 1981 Jan; 19(1):73-7. PubMed ID: 7461027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
    Sawada Y; Hanano M; Sugiyama Y; Iga T
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of acute renal failure on the protein binding of drugs in animals and in man.
    Belpaire FM; Bogaert MG; Mussche MM
    Eur J Clin Pharmacol; 1977; 11(1):27-32. PubMed ID: 832654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
    Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
    Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hydroxylation of drugs- a pharmacogenetic problem?
    Evans DA
    Proc R Soc Med; 1970 Feb; 63(2):178. PubMed ID: 4191705
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of acute renal failure on the disposition of cefoperazone.
    Katayama H; Yasuhara M; Hori R
    J Pharm Pharmacol; 1999 Mar; 51(3):361-6. PubMed ID: 10344639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum binding of quinidine in experimental acute renal failure.
    Belpaire F; Bogaert M; De Broe M; Mussche M
    Pharmacology; 1977; 15(4):311-7. PubMed ID: 896946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetically dependent variability of drug effects].
    Goedee HW; Altland K
    Med Klin; 1970 Aug; 65(35):1507-17. PubMed ID: 4933855
    [No Abstract]   [Full Text] [Related]  

  • 19. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-linear plasma protein binding on unbound and total plasma phenylbutazone concentrations in cows.
    Boudinot FD; Williams RJ; Smith JA
    J Vet Pharmacol Ther; 1990 Jun; 13(2):132-6. PubMed ID: 2384903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.